Joao Siffert M.D., SVP, R&D at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 34,709 shares at $16.93 ($589K) on 2014-12-18, disclosed to the SEC on 2014-12-22.
Scheduled sale ($589k) by SVP, R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.93 | 15,505 | $262K | 44.6% |
| 2 | $16.99 | 19,204 | $326K | 55.4% |
| Total | $16.96 avg | 34,709 | $589K | 100% |
| Filing → |
| AVNR | SELL | 2014-05-30 | $70K | — | Filing → |
| AVNR | SELL | 2013-12-20 | $16K | — | Filing → |
| AVNR | SELL | 2013-09-19 | $89K | — | Filing → |